Efficacy News and Research

RSS
Accelerated partial breast irradiation does not compromise survival

Accelerated partial breast irradiation does not compromise survival

BioTrends tracks uptake of Yervoy and Zelboraf for advanced melanoma

BioTrends tracks uptake of Yervoy and Zelboraf for advanced melanoma

NEJM publishes results from Celgene’s REVLIMID phase III studies on MM

NEJM publishes results from Celgene’s REVLIMID phase III studies on MM

ICD therapy significantly reduces mortality in patients with moderate heart failure

ICD therapy significantly reduces mortality in patients with moderate heart failure

FDA ADAC recommends approval of Gilead’s Truvada for HIV

FDA ADAC recommends approval of Gilead’s Truvada for HIV

Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial

Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial

New technique measures brain activity in large populations of nerve cells

New technique measures brain activity in large populations of nerve cells

Newly diagnosed schizophrenia patients continue to use oral Abilify as first-line therapy

Newly diagnosed schizophrenia patients continue to use oral Abilify as first-line therapy

Resverlogix completes RVX-208 Phase 2b trial on CVD

Resverlogix completes RVX-208 Phase 2b trial on CVD

Truvada deemed safe & effective in HIV infection risk reduction

Truvada deemed safe & effective in HIV infection risk reduction

Probiotics may reduce the risk of antibiotic associated diarrhoea

Probiotics may reduce the risk of antibiotic associated diarrhoea

Toshiba introduces two new software enhancements to facilitate TAVR procedures

Toshiba introduces two new software enhancements to facilitate TAVR procedures

C3BS’s C-Cath Injection Catheter receives CE Marking

C3BS’s C-Cath Injection Catheter receives CE Marking

Non-drug therapy with NeuroStar TMS improves depression symptoms and QOL

Non-drug therapy with NeuroStar TMS improves depression symptoms and QOL

IBN develops biochip for investigating the effect of drugs on cancer stem cells

IBN develops biochip for investigating the effect of drugs on cancer stem cells

Two studies suggest long-term value of Deplin in treating MDD

Two studies suggest long-term value of Deplin in treating MDD

iBio receives U.S. patent for iBioModulator platform

iBio receives U.S. patent for iBioModulator platform

Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill

Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill

'Good' cholesterol may not protect against coronary heart disease

'Good' cholesterol may not protect against coronary heart disease

Rexahn submits Phase II protocol for Archexin clinical study for ovarian cancer

Rexahn submits Phase II protocol for Archexin clinical study for ovarian cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.